跳轉至內容
Merck
全部照片(1)

Key Documents

C1540000

氯己定 二盐酸盐

European Pharmacopoeia (EP) Reference Standard

同義詞:

1,6-双(N5-[对氯苯基]-N1-双胍)己烷;1,1′-己基双(5-[对氯苯基]双胍), 洗必泰

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C22H30Cl2N10 · 2HCl
CAS號碼:
分子量::
578.37
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

chlorhexidine

製造商/商標名

EDQM

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

pharmaceutical (small molecule)

格式

neat

SMILES 字串

Cl.Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1

InChI

1S/C22H30Cl2N10.2ClH/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18;;/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34);2*1H

InChI 密鑰

WJLVQTJZDCGNJN-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Chlorhexidine dihydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Maristela Dutra-Correa et al.
The journal of adhesive dentistry, 15(3), 287-292 (2013-04-06)
This study tested the hypothesis that 2% chlorhexidine (CHX) does not affect the 18-month clinical performance of two dentin adhesives, XP Bond (XPB) and XENO V (XEN). A total of 120 noncarious cervical lesions (NCCL) were selected and assigned to
Patricia Conley et al.
Nursing, 43(7), 18-23 (2013-06-20)
Several studies have demonstrated that oral care with chlorhexidine gluconate (CHG) 0.12% solution reduces the incidence of ventilator-associated pneumonia (VAP) in mechanically ventilated patients with endotracheal tubes in the ICU. Minimal evidence shows the effectiveness of any oral care protocols
Daily chlorhexidine bathing and hospital-acquired infection.
Jean-Jacques Parienti et al.
The New England journal of medicine, 368(24), 2331-2331 (2013-06-14)
Daily chlorhexidine bathing and hospital-acquired infection.
Anthony L Esposito
The New England journal of medicine, 368(24), 2330-2330 (2013-06-14)
Rengin Attin et al.
Australian orthodontic journal, 29(1), 52-57 (2013-06-22)
The aim of this prospective study was to evaluate the re-colonisation pattern of Streptococcus mutans (MS) in highlevel MS-colonised patients with fixed orthodontic appliances following 40% chlorhexidine varnish application prior to bracket placement. The subjects of this single-blinded clinical trial

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務